Medindia

X

CVS Caremark to Participate in the Citi Investment Research 2011 Global Consumer Conference

Friday, May 20, 2011 General News J E 4
Advertisement

WOONSOCKET, R.I., May 19, 2011 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) today announced that Larry Merlo, President and Chief Executive Officer, will be making a presentation to investors at the Citi Investment Research 2011 Global Consumer Conference on May 25, 2011. Mr. Merlo is scheduled to present at 2:10 pm EDT.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

An audio webcast of the presentation will be broadcast simultaneously through the Investor Relations portion of the CVS Caremark website for all interested parties. To access the webcast, visit http://info.cvscaremark.com/investors. This webcast will be archived and available on the website for a one-year period following the presentation.

About the Company:

CVS Caremark is the largest pharmacy health care provider in the United States. Through our integrated offerings across the entire spectrum of pharmacy care, we are uniquely positioned to provide greater access to engage plan members in behaviors that improve their health, and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 65,000 pharmacies, including more than 7,200 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com.

SOURCE CVS Caremark Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Hospital Ratings Study Flawed, According to Health...
S
Overview of CSL Behring Innovations in Recombinant...